Tag Archives: The Stem Cell Blog

UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD – UConn Today

Continue reading

2018-04-26 NEWS

UConn Today

UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD
UConn Today
A ground-breaking clinical trial focusing on Glycogen Storage Disease (GSD) Type Ia will be hosted by the GSD Program at Connecticut Children’s Medical Center and UConn Health, under the direction of pediatric endocrinologist and scientist Dr. David

and more »

Continue reading

2018-04-26 NEWS

FierceBiotech

Jennifer Doudna’s new CRISPR company will tackle disease detection
FierceBiotech
“In CRISPR, you type a guide RNA into a protein to tell it what to find.” It then looks for whatever sequence is complementary to the guide RNA. Instead of using the technology to target and then delete or replace a faulty sequence, Mammoth is using it

Continue reading

2018-04-26 NEWS

The Verge

This company is making an at-home CRISPR kit to find out what’s making you sick
The Verge
A new biotech company co-founded by CRISPR pioneer Jennifer Doudna is developing a device that uses CRISPR to detect all kids of diseases like malaria, tuberculosis, and Zika. The tech is still just in prototype phase, but research in the field is
A New Startup Wants to Use Crispr to Diagnose DiseaseWIRED
Mammoth Biosciences launches a CRISPR-powered search engine for disease detectionTechCrunch
Home Tests in Mind, Doudna Startup Races Rivals in CRISPR DiagnosticsXconomy
Endpoints News –San Francisco Business Times
all 12 news articles »
Continue reading

2018-04-26 NEWS

Spinout from Jennifer Doudna’s UC lab looks to turn CRISPR into an easy-to-use diagnostic tool
San Francisco Business Times
A UC Berkeley spinout hoping to make disease detection as simple as at-home pregnancy tests looks to take the hot CRISPR gene-editing technology in a new direction. Mammoth Biosciences Inc. is emerging from stealth mode with a license for technology

Continue reading

2018-04-26 NEWS

CBC.ca

‘This is not experimental anymore’: How immunotherapy is being …
CBC.ca
This is an excerpt from Second Opinion, a weekly roundup of eclectic and under-the-radar health and medical science news emailed to subscribers every Saturday morning. If you haven’t subscribed yet, you can do that by clicking here. Last Monday
Better lung cancer treatment? Immunotherapy drug Keytruda boosts …Genetic Literacy Project

all 3 news articles »